HealthEquity (HQY) Insider William Gassen Buys 2,877 Shares
Insider William Gassen acquired 2,877 shares of HealthEquity, Inc. on June 25, 2026.
Reviewed by automated data checks against the source filing. How we make and check alerts
William Gassen bought 2,877 shares of HealthEquity, Inc. ($HQY) on June 25, 2026. The trade was reported to the SEC in a Form 4 filing.
Since the trade, $HQY is up 14.2% after 1 week, up 18.7% after 1 month and up 10.3% to date (from the $83.43 close on Jun 25, 2026).
HQY
HealthEquity, Inc.
Key Points
- William Gassen purchased 2,877 shares of HealthEquity, Inc. on June 25, 2026, with shares trading at $88.58.
- HealthEquity, Inc. has a market cap of $7.39 billion and a P/E ratio of 33.1, with shares ranging from $72.76 to $106.60 over the past year.
- Analysts from Citizens and RBC Capital maintained a 'buy' rating, with price targets of $111 and $108, respectively.
Get $HQY trade alerts by text
We text you when insiders, Congress or big funds trade $HQY. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated HealthEquity, Inc. alert may contain errors. Disclosures
On June 25, 2026, William Gassen, an insider at HealthEquity, Inc. (NasdaqGS: HQY), purchased 2,877 shares of the company. The shares were acquired without a specified price, and the transaction was not part of a pre-planned trading program. Shares of HealthEquity traded at $88.58 on Tuesday.
Insider Buying and Selling at HealthEquity, Inc.
William Gassen wasn't the only insider buying shares on June 25, 2026. Other insiders, including Gayle Furgurson Wellborn, Stuart Parker, Evelyn Dilsaver, Debra Charlotte McCowan, and Adrian Dillon, also each acquired 2,877 shares. These purchases were made without a specified price and were similarly not pre-planned.
HealthEquity, Inc. Stock Down 6.9%
Shares of HealthEquity, Inc. traded near $88.58 on Tuesday. The company boasts a market capitalization of approximately $7.39 billion, with a P/E ratio of 33.1 and a forward P/E of 16.1. The stock has seen a 52-week low of $72.76 and a high of $106.60. Its 50-day moving average is $85.12, while the 200-day moving average stands at $88.09. HealthEquity maintains a strong current ratio of 3.44 and a quick ratio of 2.85, with a debt-to-equity ratio of 48.09.
Analysts Set New Price Targets
Analysts have been positive on HealthEquity, Inc., with Citizens maintaining a 'buy' rating and setting a price target of $111 on June 1, 2026. RBC Capital also maintained its 'buy' rating with a target of $108 on May 29, 2026. Barrington Research echoed this sentiment with a 'buy' rating and a $110 target on May 22, 2026. The consensus among analysts is a 'buy' recommendation, with an average target price of $115.56 based on 16 opinions.
About HealthEquity, Inc.
HealthEquity, Inc. is a healthcare company based in Draper, Utah, providing technology-enabled services to consumers and employers in the U.S. It offers health savings accounts, flexible spending accounts, and health reimbursement arrangements, among other services. The company also assists with commuter benefits and COBRA continuation services. Led by CEO Scott R. Cutler, HealthEquity employs approximately 2,814 people.
Bottom Line
William Gassen's purchase of HealthEquity shares underscores insider confidence in the company's prospects. Investors often track insider buying as a potential indicator of a company's future performance. However, it's important to remember that such purchases don't guarantee future stock movement. HealthEquity, Inc. continues to attract positive analyst attention, with a consensus 'buy' rating and several recent price target affirmations.
Related Filing Alerts
Source: William Gassen's Form 4 filing on $HQY (Jun 25, 2026). Find the original filing: HQY Form 4 filings on SEC EDGAR. Written by software, not financial advice. How we make alerts